Search

The article examines whether medical marijuana can be indicated for glaucoma, citing some evidence supporting the use of marijuana for nausea and vomiting related to chemotherapy, specific pain syndromes, and spasiticity from multiple sclerosis. It notes the claims of medical organizations American Academy of Ophthalmology and the American Glaucoma Society stating marijuana not a proven treatment for glaucoma. The U.S. states where medical marijuana is legal are also noted.

The article reports on the role of marijuana in optometry. Topics discussed include the case of a child named Charlotte Figi whose seizure was reduced through a type of marijuana with high level of cannabidiol (CBD) but low tetrahydrocannobinol (THC), the use of marijuana for the treatment of glaucoma, and the medical report on marijuana released by the Institute of Medicine in 1997. Highlights of the Optometry's Meeting of the American Optometric Association as of August 2015 are discussed.

The article reports on the statement released by the American Academy of Ophthalmology (AAOphth) in which it reiterated its stance on medical marijuana as an effective long-term treatment for glaucoma.